COMBINATION, KIT AND METHOD OF REDUCING INTRAOCULAR PRESSURE

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20160367586A1
SERIAL NO

15158188

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention is directed to a combination or a kit comprising a prostaglandin analog and an adenosine receptor A1 agonist and to a method of reducing intraocular pressure (IOP) in a subject using such combination or kit. The invention is particularly directed to a combination of latanoprost marketed under the brand Xalatan™ and Compound A.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INOTEK PHARMACEUTICALS CORPORATION100 CUMMINGS CENTER SUITE 419E BEVERLY MA 01915

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
BAUMGARTNER, Rudolf A Sudbury, US 5 26
KIM, Norman N Westford, US 9 54
MCCAULEY, Thomas G Cambridge, US 11 188
MCVICAR, William K Sudbury, US 22 74

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation